Table 1.
The activity of 14 antimicrobial agents against 160 clinically isolated strains
| Antibiotic | Number (%) of 160 strains
|
||
|---|---|---|---|
| Sensitive | Intermediary | Resistant | |
| Aminoglycoside | |||
| Amikacin | 146 (91.2) | 0 (0) | 14 (8.8) |
| Gentamicin | 132 (82.5) | 9 (5.6) | 19 (11.9) |
| Tobramycin | 151 (94.4) | 1 (0.6) | 8 (5) |
| Quinolones | |||
| Ciprofloxacin | 99 (61.9) | 9 (5.6) | 52 (32.5) |
| Levofloxacin | 79 (49.4) | 17 (10.6) | 64 (40.0) |
| Polypeptides | |||
| Ploymixin | 160 (100) | 0 (0) | 0 (0) |
| Monolactams | |||
| Aztreonam | 52 (32.5) | 37 (23.1) | 71 (44.4) |
| Cephalosporins | |||
| Ceftazidime | 103 (64.4) | 9 (5.6) | 48 (30) |
| Cefepime | 84 (52.5) | 24 (15.0) | 52 (32.5) |
| Carbapenems | |||
| Imipenem | 63 (39.4) | 4 (2.5) | 93 (58.1) |
| Meropenem | 67 (41.9) | 7 (4.4) | 86 (53.7) |
| Ureidopenicillins | |||
| Piperacillin | 73 (45.6) | 18 (11.3) | 69 (43.1) |
| β-Lactam/inhibitor complex | |||
| Piperacillin/tazobactam | 85 (53.1) | 20 (12.5) | 55 (34.4) |
| Cefoperazone sodium/sulbactam | 78 (48.8) | 29 (18.1) | 53 (33.1) |